Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Review Question - QID 104235

In scope icon M 6 E
QID 104235 (Type "104235" in App Search)
A 55-year-old obese woman with a past medical history of a pulmonary embolism presents with shortness of breath and chest pain. It started this morning, and she can't recall any preceding symptoms. She feels short of breath and has chest pain with deep breaths. Her temperature is 97.6°F (36.4°C), blood pressure is 117/77 mmHg, pulse is 120/min, respirations are 22/min, and oxygen saturation is 92% on room air. A CTA is performed and the patient is subsequently treated with warfarin and admitted to the hospital. On hospital day 2, the patient complains of leg pain and demonstrates the finding in Figure A. Which of the following is the most likely etiology for this patient's presentation?
  • A

Allergic medication reaction

1%

1/70

Hereditary disorder

11%

8/70

Neisseria meningitidis

6%

4/70

Septic emboli

64%

45/70

Superficial vein thrombosis

16%

11/70

  • A

Select Answer to see Preferred Response

bookmode logo Review TC In New Tab

This patient is presenting with leg pain and a necrotic patch on their leg after starting warfarin (without heparin being given) and is most likely experiencing warfarin-induced skin necrosis. This condition often occurs in patients who have protein C deficiency (a hereditary disorder).

Warfarin-induced skin necrosis presents with pain, bulla formation, and skin necrosis following initiation of warfarin. The major risk factor is protein C deficiency. Warfarin inhibits the production of proteins C/S (anticoagulants) as well as clotting factors IX, X, VII, and II. It depletes proteins C and S first, thus patients may experience a transient hypercoagulable state when starting warfarin (which is why heparin is given until the patient has a therapeutic INR). Patients with protein C/S deficiency are even at greater risk for warfarin skin necrosis given they already have low protein C/S levels. Heparin is used for anticoagulation in these patients.

Figure A displays an example of warfarin-induced skin necrosis of the lower limb with the classic necrotic skin lesion.

Incorrect Answers:
Answer 1: Allergic medication reaction may present with urticaria or edema of the upper airway. Warfarin skin necrosis is not an allergic reaction.

Answer 3: Neisseria meningitidis may cause a purpuric rash when disseminated as well as would present with a fever, hypotension, tachycardia, and adrenal failure.

Answer 4: Septic emboli may be seen in bacterial endocarditis and could present with septic pulmonary emboli in the lungs (cough and fever) or the lower extremities (severe pain).

Answer 5: Superficial vein thrombosis may present with a tender and palpable vein over the lower extremity. This pathology could possibly cause a pulmonary embolism (though it is less likely when compared to a DVT).

Bullet Summary:
Protein C/S deficiency can predispose patients to warfarin skin necrosis.

Authors
Rating
Please Rate Question Quality

4.2

  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon

(13)

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options